Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesupron + Capecitabine in Metastatic Breast Cancer
NCT00615940Phase 2Completed
- Sponsor
- Heidelberg Pharma AG
- Start
- Jul 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of Drostanolone in breast cancer, sponsored by Heidelberg Pharma AG. Started Jul 2008; status: completed.
02
Drugs
Drostanolone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00615940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615940.